BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 23 filers reported holding BIOLINERX LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | 0.0% | 2,000 | -12.1% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 2,275 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 2,275 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 2,275 | +13.8% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -77.8% | 2,000 | -77.8% | 0.00% | – |
| Q4 2017 | $9,000 | +50.0% | 9,000 | +80.0% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -89.1% | 5,000 | -87.5% | 0.00% | -100.0% |
| Q3 2016 | $46,000 | +43.8% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $32,000 | -22.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | -10.9% | 40,000 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $46,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 3,603,300 | $4,684,000 | 0.35% |
| Broadfin Capital, LLC | 3,500,000 | $4,550,000 | 0.28% |
| Opaleye Management Inc. | 250,000 | $325,000 | 0.14% |
| Benchmark Capital Advisors | 47,000 | $61,000 | 0.05% |
| NEXT Financial Group, Inc | 37,500 | $48,000 | 0.02% |
| MENTA CAPITAL LLC | 88,517 | $115,000 | 0.02% |
| Orbimed Advisors | 1,038,600 | $1,350,000 | 0.01% |
| Alyeska Investment Group, L.P. | 444,738 | $578,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 600,000 | $780,000 | 0.00% |
| Airain ltd | 14,674 | $19,000 | 0.00% |